ESRP2 and hepatocellular carcinoma: Strikingly, in line with the expression pattern of ESRP2, the PSI value of multiple splicing targets were found to be down‐regulated in both fetal hepatocytes and HCC (Figure 3F), suggesting that ESRP2 may inhibit the accumulation of fetal splicing variants in HCC.